Top

World Journal of Surgery

Published in:

01-01-2012

Impact of Preoperative Thrombocytosis on the Survival of Patients with Primary Colorectal Cancer

Authors: Kazuhito Sasaki, Kazushige Kawai, Nelson H. Tsuno, Eiji Sunami, Joji Kitayama

Published in: World Journal of Surgery | Issue 1/2012

Abstract

Background

Although thrombocytosis has been reported in patients with various types of cancer, the association between thrombocytosis and the clinicopathological features of patients with colorectal cancer (CRC) has not been fully investigated. We evaluated the clinical features associated with thrombocytosis in CRC.

Materials and methods

The medical records of 636 consecutive CRC patients undergoing surgery in our department between January 2002 and July 2008 were retrospectively reviewed. The correlation between the clinicopathological variables and the preoperative platelet count was analyzed by univariate and multivariate analyses. The impact of thrombocytosis on the prognosis of these patients was assessed, in comparison with the other clinicopathological variables.

Results

Platelet count showed significant correlation with gender, age, venous involvement, tumor size, depth of invasion, regional lymph node metastasis, distant metastasis in univariate analysis, and tumor size and depth of invasion were independent factors in multivariate analysis. The cancer-specific survival (CSS) of CRC patients with thrombocytosis was significantly shorter than that for those without thrombocytosis (P < 0.001), specifically in patients with stage III CRC (P < 0.001). Multivariate analysis indicated that thrombocytosis was an independent prognostic factor of CSS (hazard ratio = 2.96, 95% confidence interval [CI] = 1.72–5.00). Moreover, within stage II CRC, the univariate analysis revealed that disease-free survival (DFS) was associated with preoperative thrombocytosis, but not the other clinicopathological variables.

Conclusions

Preoperative thrombocytosis is not only an independent indicator of poor CSS in CRC patients but also an independent predictor of poor DFS in patients with stage II CRC.

Xu R, Zhou B, Fung PC et al (2006) Recent advances in the treatment of colon cancer. Histol Histopathol 21:867–872PubMed

McArdle CS, Hole DJ (2002) Outcome following surgery for colorectal cancer: analysis by hospital after adjustment for case-mix and deprivation. Br J Cancer 86:331–335PubMedCrossRef

O’Connell JB, Maggard MA, Ko CY (2004) Colon cancer survival rates with the new American Joint Committee on Cancer Sixth Edition staging. J Natl Cancer Inst 96:1420–1425PubMedCrossRef

Graziano F, Cascinu S (2003) Prognostic molecular markers for planning adjuvant chemotherapy trials in Dukes B colorectal cancer patients: how much evidence is enough? Ann Oncol 14:1026–1038PubMedCrossRef

McMillan DC, Crozier JE, Canna K et al (2007) Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis 22:881–886PubMedCrossRef

Jones JM, McGonigle NC, McAnespie M et al (2006) Plasma fibrinogen and serum C-reactive protein are associated with non-small cell lung cancer. Lung Cancer 53:97–101PubMedCrossRef

Lee JH, Ryu KW, Kim S et al (2004) Preoperative plasma fibrinogen levels in gastric cancer patients correlate with extent of tumor. Hepatogastroenterology 51:1860–1863PubMed

Oya M, Akiyama Y, Okuyama T et al (2001) High preoperative plasma D-dimer level is associated with advanced tumor stage and short survival after curative resection in patients with colorectal cancer. Jpn J Clin Oncol 31:388–394PubMedCrossRef

Levitan N, Dowlati A, Remick SC et al (1999) Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy, Risk analysis using Medicare claims data. Medicine (Baltimore) 78:285–291CrossRef

10.

Pedersen LM, Milman N (1996) Prognostic significance of thrombocytosis in patients with primary lung cancer. Eur Respir J 9:1826–1830PubMedCrossRef

11.

Scholz HS, Petru E, Gucer F et al (2000) Preoperative thrombocytosis is an independent prognostic factor in stage III and IV endometrial cancer. Anticancer Res 20:3983–3985PubMed

12.

Shimada H, Oohira G, Okazumi S et al (2004) Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma. J Am Coll Surg 198:737–741PubMedCrossRef

13.

Monreal M, Fernandez-Llamazares J, Pinol M et al (1998) Platelet count and survival in patients with colorectal cancer—a preliminary study. Thromb Haemost 79:916–918PubMed

14.

Taucher S, Salat A, Gnant M et al (2003) Impact of pretreatment thrombocytosis on survival in primary breast cancer. Thromb Haemost 89:1098–1106PubMed

15.

Nyasavajjala SM, Runau F, Datta S et al (2010) Is there a role for preoperative thrombocytosis in the management of colorectal cancer? Int J Surg 8:436–438PubMedCrossRef

16.

Qiu MZ, Yuan ZY, Luo HY et al (2010) Impact of pretreatment hematologic profile on survival of colorectal cancer patients. Tumour Biol 31:255–260PubMedCrossRef

17.

Kandemir EG, Mayadagli A, Karagoz B et al (2005) Prognostic significance of thrombocytosis in node-negative colon cancer. J Int Med Res 33:228–235PubMed

18.

Amitrano L, Guardascione MA, Brancaccio V et al (2002) Coagulation disorders in liver disease. Semin Liver Dis 22:83–96PubMedCrossRef

19.

Klinger MH, Jelkmann W (2002) Role of blood platelets in infection and inflammation. J Interferon Cytokine Res 22:913–922PubMedCrossRef

20.

American Joint Cancer Commission (1997) AJCC cancer staging manual. In American Joint Committee on Cancer, 5th edn. Lippincott-Raven, Philadelphia

21.

Erdemir F, Kilciler M, Bedir S et al (2007) Clinical significance of platelet count in patients with renal cell carcinoma. Urol Int 79:111–116PubMedCrossRef

22.

Ikeda M, Furukawa H, Imamura H et al (2002) Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol 9:287–291PubMedCrossRef

23.

Ding PR, An X, Zhang RX et al (2010) Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer. Int J Colorectal Dis 25:1427–1433PubMedCrossRef

24.

Benson AB, Choti MA, Cohen AM et al (2000) NCCN practice guidelines for colorectal cancer. Oncology (Williston Park) 14:203–212

25.

Benson AB, Schrag D, Somerfield MR et al (2004) American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 22:3408–3419PubMedCrossRef

26.

Blay JY, Favrot M, Rossi JF et al (1993) Role of interleukin-6 in paraneoplastic thrombocytosis. Blood 82:2261–2262PubMed

27.

Verheul HM, Pinedo HM (2003) The importance of platelet counts and their contents in cancer. Clin Cancer Res 9:3219–3221PubMed

28.

Verheul HM, Hoekman K, Lupu F et al (2000) Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas. Clin Cancer Res 6:166–171PubMed

29.

Banks RE, Forbes MA, Kinsey SE et al (1998) Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer 77:956–964PubMedCrossRef

30.

Folman CC, Linthorst GE, van Mourik J et al (2000) Platelets release thrombopoietin (Tpo) upon activation: another regulatory loop in thrombocytopoiesis? Thromb Haemost 83:923–930PubMed

31.

Jain S, Harris J, Ware J (2010) Platelets: linking hemostasis and cancer. Arterioscler Thromb Vasc Biol 30:2362–2367PubMedCrossRef

32.

Janowska-Wieczorek A, Wysoczynski M, Kijowski J et al (2005) Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer 113:752–760PubMedCrossRef

33.

Nieswandt B, Hafner M, Echtenacher B et al (1999) Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res 59:1295–1300PubMed

Title: Impact of Preoperative Thrombocytosis on the Survival of Patients with Primary Colorectal Cancer
Authors: Kazuhito Sasaki
Kazushige Kawai
Nelson H. Tsuno
Eiji Sunami
Joji Kitayama
Publication date: 01-01-2012
Publisher: Springer-Verlag
Published in: World Journal of Surgery / Issue 1/2012
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-011-1329-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Impact of Preoperative Thrombocytosis on the Survival of Patients with Primary Colorectal Cancer

Abstract

Background

Materials and methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Materials and methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2012

Complications of Bursectomy after Radical Gastrectomy for Gastric Cancer

Ghrelin Agonist TZP-101/Ulimorelin Accelerates Gastrointestinal Recovery Independently of Opioid Use and Surgery Type: Covariate Analysis of Phase 2 Data

Bridging the Gap with an Ileocolonic Graft after Extensive Colorectal Resections

Influence of Bursectomy on Operative Morbidity and Mortality After Radical Gastrectomy for Gastric Cancer: Results of a Randomized Controlled Trial

Dexamethasone for Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Thyroidectomy: Meta-analysis of Randomized Controlled Trials

The Dr. Bovary Syndrome (DBS)